Please use this identifier to cite or link to this item:
https://doi.org/10.3390/v14050967
DC Field | Value | |
---|---|---|
dc.title | Modelling the Impact of Mass Testing to Transition from Pandemic Mitigation to Endemic COVID-19 | |
dc.contributor.author | Koo, Joel R | |
dc.contributor.author | Cook, Alex R | |
dc.contributor.author | Lim, Jue Tao | |
dc.contributor.author | Tan, Ken Wei | |
dc.contributor.author | Dickens, Borame L | |
dc.date.accessioned | 2022-07-20T09:33:28Z | |
dc.date.available | 2022-07-20T09:33:28Z | |
dc.date.issued | 2022-05-01 | |
dc.identifier.citation | Koo, Joel R, Cook, Alex R, Lim, Jue Tao, Tan, Ken Wei, Dickens, Borame L (2022-05-01). Modelling the Impact of Mass Testing to Transition from Pandemic Mitigation to Endemic COVID-19. VIRUSES-BASEL 14 (5). ScholarBank@NUS Repository. https://doi.org/10.3390/v14050967 | |
dc.identifier.issn | 19994915 | |
dc.identifier.issn | 19994915 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/228951 | |
dc.description.abstract | As countries transition from pandemic mitigation to endemic COVID-19, mass testing may blunt the impact on the healthcare system of the liminal wave. We used GeoDEMOS-R, an agent-based model of Singapore’s population with demographic distributions and vaccination status. A 250-day COVID-19 Delta variant model was run at varying maximal rapid antigen test sensitivities and frequencies. Without testing, the number of infections reached 1,021,000 (899,400–1,147,000) at 250 days. When conducting fortnightly and weekly mass routine rapid antigen testing 30 days into the outbreak at a maximal test sensitivity of 0.6, this was reduced by 12.8% (11.3–14.5%) and 25.2% (22.5–28.5%). An increase in maximal test sensitivity of 0.2 results a corresponding reduction of 17.5% (15.5–20.2%) and 34.4% (30.5–39.1%). Within the maximal test sensitivity range of 0.6–0.8, test frequency has a greater impact than maximal test sensitivity with an average reduction of 2.2% in infections for each day removed between tests in comparison to a 0.43% average reduction per 1% increase in test frequency. Our findings highlight that mass testing using rapid diagnostic tests can be used as an effective intervention for countries transitioning from pandemic mitigation to endemic COVID-19. | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Virology | |
dc.subject | SARS-CoV-2 | |
dc.subject | mass testing | |
dc.subject | rapid antigen test | |
dc.subject | agent-based model | |
dc.subject | endemicity | |
dc.type | Article | |
dc.date.updated | 2022-07-19T14:43:24Z | |
dc.contributor.department | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH | |
dc.description.doi | 10.3390/v14050967 | |
dc.description.sourcetitle | VIRUSES-BASEL | |
dc.description.volume | 14 | |
dc.description.issue | 5 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Modelling the Impact of Mass Testing to Transition from Pandemic Mitigation to Endemic COVID-19.pdf | 11.37 MB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.